Regression of Type II Gastric Carcinoids in Multiple Endocrine Neoplasia Type 1 Patients with Zollinger-Ellison Syndrome after Surgical Excision of All Gastrinomas (original) (raw)

A Prospective Study of Gastric Carcinoids and Enterochromaffin-Like Cell Changes in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: Identification of Risk Factors

Massimo Marignani

The Journal of Clinical Endocrinology & Metabolism, 2008

View PDFchevron_right

Gastroduodenal neuroendocrine neoplasms including gastrinoma — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma — uaktualnione zasady postępowania (rekomen...

Marek Szczepkowski

Endokrynologia Polska

View PDFchevron_right

Carcinogenic Hypergastrinemia: Signet-Ring Cell Carcinoma in a Patient with Multiple Endocrine Neoplasia Type 1 with Zollinger-Ellison’s Syndrome

Andrea Varro

The Journal of Clinical Endocrinology & Metabolism, 2007

View PDFchevron_right

Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas

Jens Waldmann

British Journal of Surgery, 2007

View PDFchevron_right

Precursor Lesions in Patients With Multiple Endocrine Neoplasia Type 1--Associated Duodenal Gastrinomas

Aurel Perren

Gastroenterology, 2005

View PDFchevron_right

Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger-Ellison Syndrome

Jeffrey Norton

Annals of Surgery, 1986

View PDFchevron_right

Well-Differentiated Gastric Tumors/Carcinomas

Stanislas Pauwels

Neuroendocrinology, 2006

View PDFchevron_right

Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome

Ralph Arnold

Human Pathology, 1975

View PDFchevron_right

A Clinical Perspective on Gastric Neuroendocrine Neoplasia

Bernhard Svejda

Current Gastroenterology Reports, 2010

View PDFchevron_right

The spectrum and classification of gastric and duodenal neuroendocrine tumours

Carlo Capella

Current Diagnostic Pathology, 1995

View PDFchevron_right

A case of multiple gastric carcinoids associated with multiple endocrine neoplasia type 1 without hypergastrinemia

Hideo Nagai

Gastrointestinal Endoscopy, 1999

View PDFchevron_right

Gastric carcinoids: Review a propos of two cases

Constantinos Christopoulos

Annals of Gastroenterology, 2006

View PDFchevron_right

Gastric neuroendocrine tumors: Biology and management

Constantinos Christopoulos

Annals of Gastroenterology

View PDFchevron_right

Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1)

Ursula Ploeckinger

Cancers, 2012

View PDFchevron_right

Gastrinoma (Duodenal and Pancreatic)

R. Emmanuel, Stanislas Pauwels

Neuroendocrinology, 2006

View PDFchevron_right

Duodenal gastrinomas, duodenotomy, and duodenal exploration in the surgical management of Zollinger-Ellison syndrome

Janice Pasieka

World Journal of Surgery, 1993

View PDFchevron_right

Gastric carcinoids in patients with hypergastrinemia

Alberto Barroso

Journal of the American College of Surgeons, 2004

View PDFchevron_right

The Effect of Surgical Resection on the Prognosis of Gastric Neuroendocrine Tumors

Batuhan Demir

American Journal of Biomedical Science & Research, 2021

View PDFchevron_right

Endocrine Precursor Lesions of Gastroenteropancreatic Neuroendocrine Tumors

Aurel Perren

Endocrine Pathology, 2007

View PDFchevron_right

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes

Ulrich-frank Pape

Endocrine-Related Cancer

View PDFchevron_right

Gastric neuroendocrine tumors Chapter 1 Overview on Gastric Cancer

Nusret Erdogan

2017

View PDFchevron_right

Effect of chronic hypergastrinemia on human enterochromaffin-like cells: Insights from patients with sporadic gastrinomas

Bruno Annibale

Gastroenterology, 2002

View PDFchevron_right

Relationship of ECL cells and gastric neoplasia

Helge Waldum

The Yale journal of biology and medicine

View PDFchevron_right

Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients

Masayuki Imamura

World Journal of Gastroenterology, 2011

View PDFchevron_right

Classification and histogenesis of gastroenteropancreatic endocrine tumours

Carlo Capella

European Journal of Clinical Investigation, 2008

View PDFchevron_right

Routine Lymph Node Dissection Versus Duodenal Inspection Alone for the Treatment of Multiple Endocrine Neoplasia Type 1 Patients with Hypergastrinemia

Paxton Dickson

2018

View PDFchevron_right

Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience

Sergio Ortolani

Journal of Internal Medicine, 2005

View PDFchevron_right

Gastric non-secreting neuroendocrine tumor and hypochlorhydria-related hypergastrinemia: a case report

Gianluca Ianiro, Marco Pizzoferrato

Journal of Medical Case Reports, 2013

View PDFchevron_right

Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study

Antongiulio Faggiano

Endocrine, 2015

View PDFchevron_right

Histologic changes in type A chronic atrophic gastritis indicating increased risk of neuroendocrine tumor development: the predictive role of dysplastic and severely hyperplastic enterochromaffin-like cell lesions

Erminio Trespi

Human Pathology, 2013

View PDFchevron_right

Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

K. Öberg

Annals of Oncology, 2012

View PDFchevron_right

Gastrinoma: State of the Art

Peter fabri

Cancer Control, 1997

View PDFchevron_right

A prospective analysis of the frequency, location, and curability of ectopic (nonpancreaticoduodenal, nonnodal) gastrinoma

Peter Wu

Surgery, 1997

View PDFchevron_right